-
Study aim
-
The effect of Resveratrol on the expression of some genes involved in the process of apoptosis in granulosa cells in patients with polycystic ovary syndrome and its relationship with the consequences of in vitro fertilization.
-
Design
-
Clinical trial with control and intervention group, with parallel groups, triple blind, randomized, phase 3 on 40 patients, random blocking was used for randomization.
-
Settings and conduct
-
Patients referred to infertility center of Hormozgan University of Medical Sciences who are included in the study underwent ovulation induction protocol (antagonist protocol).
Granulosa cells will be collected and centrifuged on the day of ovulation. The cell pellete will be used to extract RNA. The expression of Survivin, Caspase 3, and Caspase7 genes will be evaluated using Real-time PCR.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
Women with polycystic ovary syndrome based on Rotterdam criteria, Women of childbearing age between 18 and 40 years, Candidate for in vitro fertilization, Not receiving insulin
Exclusion criteria:
FSH > 10, high grade endometriosis (III and IV), thyroid diseases, congenital adrenal hyperplasia, hyperprolactinemia, ovarian secretion tumors, lupus and autoimmune diseases, the consumption of red grapes, pistachios, peanuts and berries, sensitivity to fruits such as red grapes, pistachios and strawberries, receiving insulin, diabetes mellitus, cushing's syndrome
-
Intervention groups
-
Intervention group: Receiving 40 days of resveratrol (800 mg once daily) from the beginning of the menstrual cycle until the day of ovulation
Control group: receiving 40 days of placebo
-
Main outcome variables
-
Apoptosis, number of eggs, number of embryos, embryo quality